BioVaxys Technology Corp. C.BIOV

Alternate Symbol(s): BVAXF

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.

CSE:BIOV - Post by User

BioVaxys Technology Corp. > No pump here but I think it will close in the 70's today

<< Previous

Bullboard Posts

Next >>

Comment by kentreon Feb 19, 2021 1:10pm

63 Views

Post# 32610934

RE:No pump here but I think it will close in the 70's today

Less than 60k left in the .60 ask range. Inevitable. Any news Monday and we will see .80s

Small float tightly held. Not much on the sell side. Never know when news comes with these guys. Not like a mining company with progressive steps. BIOV has several avenues of news. The big ones haven’t come yet. Expect that in later months. Careful selling this one. I expect large up gaps in the meantime.

<< Previous

Bullboard Posts

Next >>

BMO evolves InvestorLine with enhanced tools for options trading